Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cidara Therapeutics
Cidara Therapeutics
FDA approves new antifungal as concerns grow over drug-resistant fungus
BioPharma Dive
Thu, 03/23/23 - 08:53 pm
FDA
Cidara Therapeutics
Melinta Therapeutics
antifungals
candidemia
candidiasis
Rezzayo
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
FDA advisers back Cidara and Melinta’s antifungal treatment
BioPharma Dive
Thu, 01/26/23 - 10:42 am
FDA
Cidara Therapeutics
Melinta Therapeutics
antifungals
candidemia
candidiasis
rezafungin
J&J Bets Up to $780 Million on Cidara’s Universal Influenza Treatment
BioSpace
Tue, 04/6/21 - 10:07 am
JNJ
Cidara Therapeutics
CD388
Flu
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
biotech
earnings
Immunic
Alkermes
Conatus
Aevi Genomic
Tricida
Curis
Ultragenyx
Leap Therapeutics
Cidara Therapeutics
Akcea
Spark Therapeutics
Eli Lilly
AnaptysBio
clinical trials